Akeso's Phase II trials of AK146D1 and AK138D1 approved in China
Abbott completes Exact Sciences acquisition
GE HealthCare's Photonova Spectra gains FDA clearance
HUTCHMED launches Phase III trial of HMPL-760 for DLBCL in China
TheraCryf advances lead addiction programme to final preclinical stage
Dizal meets primary endpoint in Phase 3 study of ZEGFROVY (sunvozertinib) monotherapy
Novartis to acquire PI3K-alpha inhibitor program from Synnovation in deal worth up to USD3bn
IBA and Telix partner to expand US radiopharmaceutical manufacturing capacity
Pfizer reports Phase 3 TALAPRO-3 results showing improved outcomes in metastatic prostate cancer
Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform
Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars
Avacta opens Phase 1 trial for AVA6103 cancer therapy in US
Imfinzi approved in EU for perioperative treatment of early gastric and gastroesophageal cancers
Aditxt acquires Ignite Proteomics to enhance cancer therapy selection